Financhill
Buy
62

HALO Quote, Financials, Valuation and Earnings

Last price:
$57.79
Seasonality move :
-2.44%
Day range:
$57.57 - $58.56
52-week range:
$42.01 - $70.51
Dividend yield:
0%
P/E ratio:
15.37x
P/S ratio:
6.87x
P/B ratio:
14.77x
Volume:
1.1M
Avg. volume:
2.4M
1-year change:
5.58%
Market cap:
$7.1B
Revenue:
$1B
EPS (TTM):
$3.76

Halozyme Therapeutics SEC Filings

Company Filed Form Type Description
HALO
Halozyme Therapeutics
05/07/2024 10-Q 10-Q filing on 05/07/2024 View Form
HALO
Halozyme Therapeutics
11/06/2023 10-Q 10-Q filing on 11/06/2023 View Form
HALO
Halozyme Therapeutics
08/08/2023 10-Q 10-Q filing on 08/08/2023 View Form
HALO
Halozyme Therapeutics
05/09/2023 10-Q 10-Q filing on 05/09/2023 View Form
HALO
Halozyme Therapeutics
11/08/2022 10-Q 10-Q filing on 11/08/2022 View Form
HALO
Halozyme Therapeutics
08/09/2022 10-Q 10-Q filing on 08/09/2022 View Form
HALO
Halozyme Therapeutics
05/10/2022 10-Q 10-Q filing on 05/10/2022 View Form
HALO
Halozyme Therapeutics
11/02/2021 10-Q 10-Q filing on 11/02/2021 View Form
HALO
Halozyme Therapeutics
08/09/2021 10-Q 10-Q filing on 08/09/2021 View Form
HALO
Halozyme Therapeutics
05/10/2021 10-Q 10-Q filing on 05/10/2021 View Form
HALO
Halozyme Therapeutics
11/02/2020 10-Q 10-Q filing on 11/02/2020 View Form
HALO
Halozyme Therapeutics
08/10/2020 10-Q 10-Q filing on 08/10/2020 View Form
HALO
Halozyme Therapeutics
05/11/2020 10-Q 10-Q filing on 05/11/2020 View Form
HALO
Halozyme Therapeutics
02/24/2020 10-K 10-K filing on 02/24/2020 View Form
HALO
Halozyme Therapeutics
11/12/2019 10-Q 10-Q filing on 11/12/2019 View Form
HALO
Halozyme Therapeutics
08/06/2019 10-Q 10-Q filing on 08/06/2019 View Form
HALO
Halozyme Therapeutics
05/07/2019 10-Q 10-Q filing on 05/07/2019 View Form
HALO
Halozyme Therapeutics
02/21/2019 10-K 10-K filing on 02/21/2019 View Form
HALO
Halozyme Therapeutics
11/06/2018 10-Q 10-Q filing on 11/06/2018 View Form
HALO
Halozyme Therapeutics
08/07/2018 10-Q 10-Q filing on 08/07/2018 View Form
HALO
Halozyme Therapeutics
05/10/2018 10-Q 10-Q filing on 05/10/2018 View Form
HALO
Halozyme Therapeutics
02/20/2018 10-K 10-K filing on 02/20/2018 View Form
HALO
Halozyme Therapeutics
11/07/2017 10-Q 10-Q filing on 11/07/2017 View Form
HALO
Halozyme Therapeutics
08/08/2017 10-Q 10-Q filing on 08/08/2017 View Form
HALO
Halozyme Therapeutics
05/09/2017 10-Q 10-Q filing on 05/09/2017 View Form
HALO
Halozyme Therapeutics
02/28/2017 10-K 10-K filing on 02/28/2017 View Form
HALO
Halozyme Therapeutics
11/07/2016 10-Q 10-Q filing on 11/07/2016 View Form
HALO
Halozyme Therapeutics
08/09/2016 10-Q 10-Q filing on 08/09/2016 View Form
HALO
Halozyme Therapeutics
05/09/2016 10-Q 10-Q filing on 05/09/2016 View Form
HALO
Halozyme Therapeutics
02/29/2016 10-K 10-K filing on 02/29/2016 View Form
HALO
Halozyme Therapeutics
11/09/2015 10-Q 10-Q filing on 11/09/2015 View Form
HALO
Halozyme Therapeutics
08/11/2015 10-Q 10-Q filing on 08/11/2015 View Form
HALO
Halozyme Therapeutics
08/10/2015 10-Q 10-Q filing on 08/10/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
71
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
72
SBET alert for Jul 18

SharpLink Gaming [SBET] is down 2.6% over the past day.

Buy
68
MCRI alert for Jul 18

Monarch Casino & Resort [MCRI] is up 19.81% over the past day.

Sell
41
NEGG alert for Jul 18

Newegg Commerce [NEGG] is up 17.85% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock